Awards
Our History
More than 100 combined years of research produced a series of patents that LifePulse™ Corporation acquired in 2020, as Pulsed Electrical Fields became one of the most important technologies in biotech. LifePulse™ was founded by Gary Strange in 2018.
Our Mission
To make this technology available in the United States first, then worldwide — beginning with pancreatic tumor trials in human medicine.
Our Patents
$37M of non-dilutive research grants from the NIH, NCI and others have produced our growing list of patents that are the foundation of the IntelliPulse™ platform.
About LifePulse™ Corporation
US engineered and manufactured, from research bench to clinical practice
Bob Roda
Extensive experience and a proven record of success leading teams and building businesses across MedTech, Diagnostics, and Pharmaceuticals.
Dr. Chris Slachta, Ph.D., M.B.A.
Combines scientific rigor with operational excellence, driving growth across the healthcare spectrum.
Bill Gilmour
Seasoned finance executive with extensive operating and M&A experience driving financial strategy and growth.
Gary Strange
Founder of LifePulse™ Corporation with 30+ years of business leadership, now leading the Animal Health division.
Dr. Paula de Marval
Highly motivated scientific director with deep knowledge in cancer biology and oncology drug discovery.
Scientific & Regulatory Advisory Board
Chelsea Tripp, DVM, ACVIM (Oncology)
Recognized veterinary-technology expert and key opinion leader.
Alexander Fleming, MD
Founder of Kinexum, an FDA translational-guidance firm.
Dr. C Richard Piazza
Former CEO of Vital Therapies (NASDAQ: VTL); led the successful divestiture of SoloPak Pharmaceuticals to Smith & Nephew.
Gary Strange
Founder of LifePulse™ Corporation with 30+ years of business leadership, now leading the Animal Health division.
Donald G. Fell
Sits on four NASDAQ-listed boards, bringing deep business acumen to LifePulse™ Corporation.
Dr. Gerald Sokol, MD
Practicing physician boarded in radiation oncology, internal medicine, and medical oncology, with decades of clinical trial experience and board leadership.
Bob Roda
Highly skilled leader with deep experience across public and private companies.
Greg Walters
Former securities attorney and serial entrepreneur, including a med-device launch through FDA approval.
Trinity Bui
39 years in finance and investment; founder of TFIC; holds an MBA in Finance.
GRANT AWARDS
Competitively awarded, non-dilutive funding
NATIONAL INSTITUTES OF HEALTH
$225,000
STTR Award
Awarded May 2023
NATIONAL INSTITUTES OF HEALTH
$2M
SBIR Direct to Phase II
Awarded September 2025
Open roles — coming soon
We are not actively posting roles right now, but we always want to hear from strong candidates.
Submit your resume
De-risked path
Veterinary traction funds and validates entry into human oncology.
Proven technology
Combined revenue of nearly $1M since launch, with the platform in clinical use across US veterinary centers.
IP position
Both US and PCT patents, providing a solid wall of protection for years to come.
Clear direction
Defined roadmap through 510(k) clearance and acquisition readiness.